Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

Go back to Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies
(NASDAQ: SVRA) Delayed: 5.59 +0.10 (1.82%)
Previous Close $5.49    52 Week High $ 
Open $5.54    52 Week Low $ 
Day High $5.64    P/E N/A 
Day Low $5.50    EPS $ 
Volume 3,035,163